“MGI’s platforms like Stereo-seq and FluoXpert are transforming biomedical research—bringing imaging, sequencing, and customization together to accelerate discovery and improve patient care.”

"We are thrilled at the prospect of merging our expertise with MGI’s sequencing prowess to bring forth the most cost-effective and scalable full-length scRNA-seq solutions to date."

"We are deeply impressed about the developments of MGI technology. They think the technology from bottom up, which is crucial for driving real innovation in clinical genomics."